119 related articles for article (PubMed ID: 7093898)
1. Prognostic factors in chondrosarcoma: a comparative study of cellular DNA content and clinicopathologic features.
Kreicbergs A; Boquist L; Borssén B; Larsson SE
Cancer; 1982 Aug; 50(3):577-83. PubMed ID: 7093898
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of nuclear DNA content in chondrosarcoma.
Kreicbergs A; Zetterberg A; Söderberg G
Anal Quant Cytol; 1980 Dec; 2(4):272-9. PubMed ID: 7469202
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of nuclear DNA content in chondrosarcoma.
Herget GW; Neuburger M; Adler CP
Ann Diagn Pathol; 2000 Feb; 4(1):11-6. PubMed ID: 10684375
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy alterations detected during dedifferentiation of periosteal chondrosarcoma.
Murata H; Kusuzaki K; Kuzuhara A; Takeshita H; Nakamura S; Tsuji Y; Hirasawa Y; Ashihara T
Anticancer Res; 1999; 19(3B):2285-8. PubMed ID: 10472345
[TBL] [Abstract][Full Text] [Related]
6. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases.
Oliveira AM; Sebo TJ; McGrory JE; Gaffey TA; Rock MG; Nascimento AG
Mod Pathol; 2000 Aug; 13(8):900-8. PubMed ID: 10955458
[TBL] [Abstract][Full Text] [Related]
7. [Comparative DNA cytometric and cytogenetic ploidy determination of chondrosarcoma and osteosarcoma].
Werner M; Rieck J; Heintz A; Pösl M; Delling G
Pathologe; 1996 Sep; 17(5):374-9. PubMed ID: 8992480
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
[TBL] [Abstract][Full Text] [Related]
9. DNA cytometry of osteosarcoma.
Bauer HC
Acta Orthop Scand Suppl; 1988; 228():1-39. PubMed ID: 3063059
[TBL] [Abstract][Full Text] [Related]
10. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
11. DNA flow cytometric analysis of chest-wall chondroma and chondrosarcoma.
Shih CS; Wang LS; Yang SS; Fahn HJ; Wu LH; Chen WY; Huang MH
Scand J Thorac Cardiovasc Surg; 1996; 30(3-4):157-61. PubMed ID: 8976036
[TBL] [Abstract][Full Text] [Related]
12. p53 expression and DNA ploidy of cartilage lesions.
Coughlan B; Feliz A; Ishida T; Czerniak B; Dorfman HD
Hum Pathol; 1995 Jun; 26(6):620-4. PubMed ID: 7774891
[TBL] [Abstract][Full Text] [Related]
13. Chondrosarcoma of bone. A clinical and DNA flow cytometric study.
Heliö H; Karaharju E; Böhling T; Kivioja A; Nordling S
Eur J Surg Oncol; 1995 Aug; 21(4):408-13. PubMed ID: 7664909
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients.
Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P
Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594
[TBL] [Abstract][Full Text] [Related]
15. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
16. Chondrosarcoma of bone: a statistical analysis of prognostic factors.
Wang JW; Ger LP; Shih CH; Hsieh MC
J Formos Med Assoc; 1991 Oct; 90(10):998-1003. PubMed ID: 1685183
[TBL] [Abstract][Full Text] [Related]
17. Cartilaginous tumors: prognostic applications of cytophotometric DNA analysis.
Adler CP; Herget GW; Neuburger M
Cancer; 1995 Oct; 76(7):1176-80. PubMed ID: 8630894
[TBL] [Abstract][Full Text] [Related]
18. Nuclear DNA content and pathology in radically treated pancreatic carcinoma. The prognostic significance of DNA ploidy, histology and nuclear grade.
Rugge M; Sonego F; Sessa F; Leandro G; Capella C; Sperti C; Pasquali C; Di Mario F; Pedrazzoli S; Ninfo V
Cancer; 1996 Feb; 77(3):459-66. PubMed ID: 8630952
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
20. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
